Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient.

Cold Spring Harbor molecular case studies - 1 Dec 2020

Welter Lisa, Xu Liya, McKinley Dillon, Dago Angel E, Prabakar Rishvanth K, Restrepo-Vassalli Sara, Xu Kevin, Rodriguez-Lee Mariam, Kolatkar Anand, Nevarez Rafael, Ruiz Carmen, Nieva Jorge, Kuhn Peter, Hicks James

Abstract excerpt

Currently, clinical characterization of metastatic breast cancer is based on tissue samples taken at time of diagnosis. However, tissue biopsies are invasive and tumors are continuously evolving, which indicates the need for minimally invasive longitudinal assessment of the tumor. Blood-based liquid biopsies provide minimal invasive means for serial sampling over the course of treatment and the opportunity to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Estrogen Receptor alpha

Share to Genomics

Share to Liquid Biopsy

Share to Neoplastic Cells, Circulating

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 33203646
DOI: 10.1101/mcs.a005819
PMCID: PMC7784493

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient.PMID 33203646Read ↗

Dissecting Tumor Heterogeneity by Liquid Biopsy—A Comparative Analysis of Post-Mortem Tissue and Pre-Mortem Liquid Biopsies in Solid NeoplasiasSemantic proximity Read ↗

Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.Semantic proximity Read ↗

An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancerSemantic proximity Read ↗

Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.Semantic proximity Read ↗

An Omic and Multidimensional Spatial Atlas from Serial Biopsies of an Evolving Metastatic Breast CancerSemantic proximity Read ↗

Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a reviewSemantic proximity Read ↗

From Static to Dynamic: Adaptive Molecular Subtyping in Treated Breast Cancers—Evidence from Single‐Center Retrospective Cohort StudySemantic proximity Read ↗

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapiesSemantic proximity Read ↗

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read ↗

Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Semantic proximity Read ↗

Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer.Semantic proximity Read ↗

Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.